Background/Aims Immune and inflammatory cells respond to multiple pathological hits in the development of nonalcoholic steatohepatitis (NASH) and fibrosis. Relatively little is known about how their type and function change through the non-alcoholic fatty liver disease (NAFLD) spectrum. Here we used multi-dimensional mass cytometry and a tailored bioinformatic approach to study circulating immune cells sampled from healthy individuals and people with NAFLD.
Methods Cytometry by time of flight using 36 metal-conjugated antibodies was applied to peripheral blood mononuclear cells (PBMCs) from biopsy-proven NASH fibrosis (late disease), steatosis (early disease), and healthy patients. Supervised and unsupervised analyses were used, findings confirmed, and mechanisms assessed using independent healthy and disease PBMC samples.
Result s: Of 36 PBMC clusters, 21 changed between controls and disease samples. Significant differences were observed between diseases stages with changes in T cells and myeloid cells throughout disease and B cell changes in late stages. Semi-supervised gating and re-clustering showed that disease stages were associated with fewer monocytes with active signalling and more inactive NK cells; B and T cells bearing activation markers were reduced in late stages, while B cells bearing co-stimulatory molecules were increased. Functionally, disease states were associated with fewer activated mucosal-associated invariant T cells and reduced toll-like receptor-mediated cytokine production in late disease.
Conclusions A range of innate and adaptive immune changes begin early in NAFLD, and disease stages are associated with a functionally less active phenotype compared to controls. Further study of the immune response in NAFLD spectrum may give insight into mechanisms of disease with potential clinical application.
Citations
Citations to this article as recorded by
On-chip characterization of cell mechanics assisted by external physical fields and artificial intelligence Jingjin Ge, Chenhao Bai, Zhuo Chen, Toshio Fukuda, Tatsuo Arai, Xiaoming Liu Lab on a Chip.2026;[Epub] CrossRef
Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study Yu Li, Xiaodan Lv, Jianing Lin, Shiquan Li, Guangfu Lin, Zhixi Huang, Deyi Chen, Lichun Han, Lingling Zhan, Xiaoping Lv Open Medicine.2025;[Epub] CrossRef
Mitochondrial dysfunction in PBMC: a potential sensor for metabolic dysfunction-associated steatotic liver disease and therapeutic insight for NAD+-increasing strategies Julia Niño-Narvión, Joana Rossell, Marina Idalia Rojo-López, Estefanía Moreira, Eder Mateus, Antonio José Ruiz-Alcaraz, Bruno Ramos-Molina, Elizabeth Martínez-Rojo, Laurent O. Martinez, Maria Galán, Josep Julve Exploration of Digestive Diseases.2025;[Epub] CrossRef
The Interplay of Cross‐Organ Immune Regulation in Inflammation and Cancer Jie Dou, Jinzuo Jiang, Yangtao Xue, Xiaoqi Jiang, Yongzhuo Jiang, Peng Xiao, Junjie Xu MedComm.2025;[Epub] CrossRef
Macrophage and inflammation in diabetes and metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeutic strategies Chun-Ye Zhang, Shuai Liu, Ming Yang World Journal of Diabetes.2025;[Epub] CrossRef
Paired snRNA-seq and scRNA-seq analysis of MASLD patients to identify early-stage markers for disease progression Suebin Park, Su-Hyeon Lee, Se-eun Han, Beom Kyung Kim, Byungjin Hwang Hepatology Communications.2025;[Epub] CrossRef
Alcohol‐Related Liver Disease and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Molecular Pathogenesis and Therapeutic Interventions Yupin Tan, Yirui Hu, Ye Yang, Huikuan Chu MedComm.2025;[Epub] CrossRef
MAIT Cells in Liver Disease Adiba I. Azad, Florencia Gutierrez, Gregory J. Gores Cells.2025; 15(1): 69. CrossRef
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies Maurizio Parola, Massimo Pinzani Molecular Aspects of Medicine.2024; 95: 101231. CrossRef
Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications Ziwei Guo, Qinjuan Wu, Pengfei Xie, Jiuchong Wang, Wenliang Lv Frontiers in Immunology.2024;[Epub] CrossRef
The Important Roles of Natural Killer Cells in Liver Fibrosis Ming Yang, Ethan Vanderwert, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li Biomedicines.2023; 11(5): 1391. CrossRef
First
Prev
